Effects of Lobeglitazone, a New Thiazolidinedione, on Osteoblastogenesis and Bone Mineral Density in Mice

BackgroundBone strength is impaired in patients with type 2 diabetes mellitus despite an increase in bone mineral density (BMD). Thiazolidinedione (TZD), a peroxisome proliferator activated receptor γ agonist, promotes adipogenesis, and suppresses osteoblastogenesis. Therefore, its use is associated...

Volledige beschrijving

Bibliografische gegevens

Hoofdauteurs:	Kyoung Min Kim, Hyun-Jin Jin, Seo Yeon Lee, Hyo Jin Maeng, Gha Young Lee, Tae Jung Oh, Sung Hee Choi, Hak Chul Jang, Soo Lim
Formaat:	Artigo
Taal:	Inglês
Gepubliceerd in:	Korean Endocrine Society 2017-09-01
Reeks:	Endocrinology and Metabolism
Onderwerpen:	Lobeglitazone Thiazolidinediones Bone and bones Bone density Osteoblasts
Online toegang:	https://e-enm.org/Synapse/Data/PDFData/2008ENM/enm-32-389.pdf
Tags:	Voeg label toe Geen labels, Wees de eerste die dit record labelt!